Investigation of elastomeric materials for bolus using stereolithography printing technology in radiotherapy.

PURPOSE: An investigation was conducted of an elastomeric material, VisiJet M2 (3D systems, USA) for use as 3D bolus within high energy photon beams for radiotherapy. Personalized conformal bolus material on complex structures like the nose can be challenging. This material was evaluated for its clinical feasibility due to its pliability and comfort compared to alternatives. METHOD: Regular slabs of bolus were created of various thicknesses for dosimetric and non-dosimetric characterization. Verification culminated with the creation of a custom nose bolus for an end to end verification using an anthropomorphic head phantom. In vivo dosimetry using Gafchromic EBT3 (Ashland, USA) film validated delivered doses from a 6 MV conformal field and a pair of 6 MV volumetric modulated arc therapy (VMAT) beams. RESULTS & CONCLUSION: Non-dosimetric and dosimetric tests were conducted to assess clinical suitability. The bolus was precisely created using stereolithographic (SLA) methods and presented a compliant and uniform water equivalent material with elastic memory. Measurement yielded a physical density of 1.10 g cm-3 and 1.06 relative to water electron density, and the bolus to skin distance was measured to be a maximum of 3 mm. A maximum measured dose difference of <2% was observed for dynamic treatment. Based on the investigation conducted, and the benefits presented for patient comfort while being uniform and water equivalent, and correctly represented within the treatment planning system (TPS), this material has the potential for clinical use for patient specific custom bolus.

Impact of Nanoparticle-Support Interactions in Co3O4/Al2O3 Catalysts for the Preferential Oxidation of Carbon Monoxide.

Different supporting procedures were followed to alter the nanoparticle-support interactions (NPSI) in two Co3O4/Al2O3 catalysts, prepared using the reverse micelle technique. The catalysts were tested in the dry preferential oxidation of carbon monoxide (CO-PrOx) while their phase stability was monitored using four complementary in situ techniques, viz., magnet-based characterization, PXRD, and combined XAS/DRIFTS, as well as quasi in situ XPS, respectively. The catalyst with weak NPSI achieved higher CO2 yields and selectivities at temperatures below 225 °C compared to the sample with strong NPSI. However, relatively high degrees of reduction of Co3O4 to metallic Co were reached between 250 and 350 °C for the same catalyst. The presence of metallic Co led to the undesired formation of CH4, reaching a yield of over 90% above 300 °C. The catalyst with strong NPSI formed very low amounts of metallic Co (less than 1%) and CH4 (yield of up to 20%) even at 350 °C. When the temperature was decreased from 350 to 50 °C under the reaction gas, both catalysts were slightly reoxidized and gradually regained their CO oxidation activity, while the formation of CH4 diminished. The present study shows a strong relationship between catalyst performance (i.e., activity and selectivity) and phase stability, both of which are affected by the strength of the NPSI. When using a metal oxide as the active CO-PrOx catalyst, it is important for it to have significant reduction resistance to avoid the formation of undesired products, e.g., CH4. However, the metal oxide should also be reducible (especially on the surface) to allow for a complete conversion of CO to CO2 via the Mars-van Krevelen mechanism.

Effect of crystallite size on the performance and phase transformation of Co3O4/Al2O3 catalysts during CO-PrOx - an in situ study.

The preferential oxidation of carbon monoxide has been identified as an effective route to remove trace amounts of CO (approx. 0.5-1.0 vol%) in the H2-rich reformate gas stream after the low-temperature water-gas shift. Instead of noble metal-based catalysts, Co3O4-based catalysts were investigated in this study as cheaper and more readily available alternatives. This study aimed at investigating the effect of crystallite size on the mass- and surface area-specific CO oxidation activity as well as on the reduction behaviour of Co3O4. Model Co3O4 catalysts with average crystallite sizes between 3 and 15 nm were synthesised using the reverse micelle technique. Results from the catalytic tests revealed that decreasing the size of the Co3O4 crystallites increased the mass-specific CO oxidation activity in the 50-200 °C temperature range. On the other hand, the surface area-specific CO oxidation activity displayed a volcano-type behaviour where crystallites with an average size of 8.5 nm were the most active within the same temperature range. In situ characterisation in the magnetometer revealed that the Co3O4 crystallites are partially reduced to metallic Co above 225 °C with crystallites larger than 7.5 nm showing higher degrees of reduction under the H2-rich environment of CO-PrOx. In situ PXRD experiments further showed the presence of CoO concurrently with metallic fcc Co in all the catalysts during the CO-PrOx runs. In all experiments, the formation of fcc Co coincided with the formation of CH4. Upon decreasing the reaction temperature below 250 °C under the reaction gas, both in situ techniques revealed that the fcc Co previously formed is partially re-oxidised to CoO.

Post-upgrade testing on a radiotherapy oncology information system with an embedded record and verify system following the IAEA Human Health Report No. 7 recommendations.

Record and verify (R&V) systems have proven that their application in radiotherapy clinics leads to a significant reduction in mis-treatments of patients. The purpose of this technical note is to share our experience of acceptance testing, commissioning and setting up a quality assurance programme for the MOSAIQ® oncology information system and R&V system after upgrading from software version 2.41 to 2.6 in a multi-vendor, multi-site environment. Testing was guided primarily by the IAEA Human Report No. 7 recommendations, but complemented by other departmental workflow specific tests. To the best of our knowledge, this is the first time successful implementation of the IAEA Human Health Report Series No. 7 recommendations have been reported in the literature.

An investigation into the accuracy of Acuros(TM) BV in heterogeneous phantoms for a (192)Ir HDR source using LiF TLDs.

The aim of this study was to evaluate the accuracy of the new Acuros(TM) BV algorithm using well characterized LiF:Mg,Ti TLD 100 in heterogeneous phantoms. TLDs were calibrated using an (192)Ir source and the AAPM TG-43 calculated dose. The Tölli and Johansson Large Cavity principle and Modified Bragg Gray principle methods confirm the dose calculated by TG-43 at a distance of 5 cm from the source to within 4 %. These calibrated TLDs were used to measure the dose in heterogeneous phantoms containing air, stainless steel, bone and titanium. The TLD results were compared with the AAPM TG-43 calculated dose and the Acuros calculated dose. Previous studies by other authors have shown a change in TLD response with depth when irradiated with an (192)Ir source. This TLD depth dependence was assessed by performing measurements at different depths in a water phantom with an (192)Ir source. The variation in the TLD response with depth in a water phantom was not found to be statistically significant for the distances investigated. The TLDs agreed with Acuros(TM) BV within 1.4 % in the air phantom, 3.2 % in the stainless steel phantom, 3 % in the bone phantom and 5.1 % in the titanium phantom. The TLDs showed a larger discrepancy when compared to TG-43 with a maximum deviation of 9.3 % in the air phantom, -11.1 % in the stainless steel phantom, -14.6 % in the bone phantom and -24.6 % in the titanium phantom. The results have shown that Acuros accounts for the heterogeneities investigated with a maximum deviation of -5.1 %. The uncertainty associated with the TLDs calibrated in the PMMA phantom is ±8.2 % (2SD).